A newly identified protein may be one of the biggest obstacles holding CAR T-cell therapy back. Researchers found that NFIL3 causes these engineered immune cells to become exhausted and lose their cancer-fighting power over time. When NFIL3 was disabled, the cells remained stronger for longer and controlled tumors more effectively in animal models.
from Top Health News -- ScienceDaily https://ift.tt/WukVy2Y
Subscribe to:
Post Comments (Atom)
-
Three treaties between the US and Hong Kong were suspended, the latest move to pressure China. from Yahoo News - Latest News & Headl...
-
At least 22 people were killed and 171 others injured on Sunday when one of Taiwan’s newer, faster trains derailed on a curve along a popula...
-
Prosecutors in Mexico have opened an investigation into former president Enrique Peña Nieto, who is accused of taking bribes in one of Latin...
No comments:
Post a Comment